Personalized Clinical Management Of Endometrial Cancer Using Liquid Biopsy, Genomics And Artificial Intelligence
ECLAI is a project initiated by CIBERONC as part of the international ERA PerMed JTC2021 call and supported by the Spanish Association Against Cancer. This project aims to personalise the clinical management of advanced endometrial cancer (EC) by combining liquid biopsy, genomics and artificial intelligence, with the ultimate goal of improving the life expectancy and quality of life of patients with EC who currently have limited clinical options. It is led by Dr. Gema Moreno-Bueno, CIBERONC IP at the UAM and MD Anderson Foundation, and Dr. Laura Muinelo, a CIBERONC researcher in the group of Rafael Lopez at the U. de Santiago Hospital. It is supported by international institutions in Poland (Medical University of Lubin), Norway (University of Bergen) and Estonia (Centre on Health Technologies).
Synthetic Data Generation Framework For Integrated Validation Of Use Cases And AI Healthcare Applications
European Federation for Cancer Images
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients
Send us three things. We tell you if the project fits a call and what it takes to prepare it.
